email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2011 - 2025
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
I-Mab Completes $104 Million IPO in the US for Biologics Portfolio
$5.00
Available
China-US Trade Agreement Specifies Patent Protection Rules for Drugs
$5.00
Available
WuXi Biologics Leases German Biologics Manufacturing Facility from Bayer
$5.00
Available
Tisenc Medical Raises $12 Million for Point-of-Care Chemiluminescence Testing
$5.00
Available
HitGen Collaborates with Kymera to Identify Protein Degradation Targets
$5.00
Available
BeiGene Announces $160 Million Agreement for China Rights to Two EUSA Orphan Biologics
$5.00
Available
Innovent Out-licenses US-Canada Rights for Avastin Biosimilar to Coherus In $45 Million Deal
$5.00
Available
Chi-Med Starts China Phase II Trial of Surufatinib/Tuoyi Combo in Solid Tumors
$5.00
Available
Sino Biopharma Signs Deal to Develop Two Novel Ambrx Biologics in China
$5.00
Available
Innovent Reports Phase III Success of PD-1 in Lung Cancer Patients
$5.00
Available
Zhiyun Health Raises $142 Million for Online Diabetes Management Website
$5.00
Available
ASK Pharm Announces $51 Million Deal for China Rights to Iron Deficiency Product
$5.00
Available
Bio-Thera Approved to Market Humira Biosimilar in China
$5.00
Available
Nantong's IOVaxis Signs $103 Million Deal for RAS Cancer Vaccines
$5.00
Available
Adagene Raises $69 Million in D Round for Novel Immunotherapies
$5.00
Available